Amarantus receives U.
Patent titled, ‘Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof’ Amarantus BioSciences, Inc. , a biotechnology organization developing MANF, a first-in-class disease-modifying therapeutic proteins, announced U today.S. Patent Number 8 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Uses and Factors Thereof. This patent addresses the discovery of MANF and its composition of matter and complements the business’s existing portfolio of issued patents and pending patent applications.But, whined a reporter, is that basically really an investigation? One at a time, reporters from the LA Instances, the NY Times, and other papers wished to enter a Talmudic hair-splitting conversation about the usage of the expressed word ‘investigation. ‘ NY and LA Situations reporters stated that they had contacted the Dept. Of Justice and discovered no investigation have been launched. Sandler stated: appearance, a complaint was filed; an FBI agent implemented up on it; the agent stated the problem would be investigated. The reporters weren’t assuaged.